Cited by 118Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingBioinformatics and Genomic Networks

Identification of neurodegenerative factors using translatome–regulatory network analysis

Open access
Brichta, Lars, Shin, William, Jackson-Lewis, Vernice, Blesa, Javier, Yap, Ee-Lynn, Walker, Zachary, Zhang, Jack, Roussarie, Jean-Pierre +4 more·2015·Nature Neuroscience

Abstract

For degenerative disorders of the CNS, the main obstacle to therapeutic advancement has been the challenge of identifying the key molecular mechanisms underlying neuronal loss. We developed a combinatorial approach including translational profiling and brain regulatory network analysis to search for key determinants of neuronal survival or death. Following the generation of transgenic mice for cell type-specific profiling of midbrain dopaminergic neurons, we established and compared translatome libraries reflecting the molecular signature of these cells at baseline or under degenerative stress. Analysis of these libraries by interrogating a context-specific brain regulatory network led to the identification of a repertoire of intrinsic upstream regulators that drive the dopaminergic stress response. The altered activity of these regulators was not associated with changes in their expression levels. This strategy can be generalized for the identification of molecular determinants involved in the degeneration of other classes of neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nn.4070

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The substantia nigra of individuals with Parkinson disease has reduced SATB1 and increased CDKN2A, MMP3, IL-6, IL-1α, and CXCL8 compared with healthy brains, suggesting increased senescence burden.

    “Compared with brains of healthy individuals, the substantia nigra of individuals with Parkinson disease has reduced levels of SATB1 (a CDKN1A repressor) and increased levels of CDKN2A, MMP3, IL-6, IL-1α and CXCL8, suggesting an increased burden of senescence106,116.”

    From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [116]

    The Results section ('Validation of novel determinants of DA neurodegeneration'; page unavailable) reports significantly decreased SATB1 transcriptional activity in substantia nigra samples from people with incipient Parkinson disease versus controls. It explicitly says SATB1 expression levels did not change, contrary to the claimed reduction in levels. Our copy does not report increases in CDKN2A, MMP3, IL-6, IL-1α or CXCL8, or an increased senescence burden. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Bulk profiling experiments comparing substantia nigra pars compacta and ventral tegmental area neurons yielded gene expression differences but could not distinguish heterogeneous populations within each anatomical cluster.

    “Bulk profiling experiments comparing SNc and VTA neurons did indeed yield some interesting gene expression differences [6–9], but suffered from the caveat that they could not distinguish heterogeneous populations within each anatomical cluster.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Brichta, L., Shin, W., Jackson-Lewis, V., Blesa, J., Yap, E.-L., Walker, Z., Zhang, J., Roussarie, J.-P., Alvarez, M. J., Califano, A., Przedborski, S., & Greengard, P.
Affiliations
  • Rockefeller University (US)
  • Columbia University (US)
Corresponding author
  • Brichta, Lars
  • Greengard, Paul
Venue
Nature Neuroscience
Published
2015-07-27
Volume
18
Issue
9
Pages
1325-1333
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2200183975
Cited by
118
References
60
Citations by year
2026: 3 · 2025: 7 · 2024: 10 · 2023: 11 · 2022: 12 · 2021: 8 · 2020: 15 · 2019: 17 · 2018: 11 · 2017: 16 · 2016: 6 · 2015: 2
FWCI
8.23
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Depósito Digital e-UCJC (submittedVersion)
Funders
  • National Institute of General Medical Sciences (T32GM008798)
  • National Institute of Neurological Disorders and Stroke (NS088009, R01NS072428, R21NS078614, NS078614, NS072428, R21NS088009)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
Parkinson's disease, neurodegeneration, dopaminergic neurons, translatome, translational profiling, regulatory network analysis, upstream regulators, neuronal survival, midbrain, transgenic mice
MeSH terms
Animals, Male, Mesencephalon, Mice, Inbred C57BL, Mice, Transgenic, Nerve Net, Substantia Nigra, Protein Biosynthesis, Neurodegenerative Diseases, Mice, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review